Publisher
Springer Science and Business Media LLC
Reference29 articles.
1. Bentata Y. Mycophenolates. The latest modern and potent immunosuppressive drugs in adult kidney transplantation: what we should know about them? Artif Organs. 2020;44:561–76.
2. Tett SE, Saint-Marcoux F, Staatz CE, Brunet M, Vinks AA, Miura M, et al. Mycophenolate, clinical pharmacokinetics, formulations, and methods for assessing drug exposure. Transplant Rev. 2011;5:47–57.
3. Bergan S, Brunet M, Hesselink DA, Johnson-Davis KL, Kunicki PK, Lemaitre F, et al. Personalized therapy for mycophenolate: consensus report by the International association on therapeutic drug monitoring and clinical toxicology. Ther Drug Monit. 2021;43:150–200.
4. Lamba V, Sanhavi K, Fish A, Altman RB, Klein TE. PharmGKB summary: mycophenolic acid pathway. Pharmacogenet Genomics. 2014;24:73–79.
5. Dalla Vecchia Genvigir F, Cerda A, Dominguez Crespo Hirata T, Hirata MH, Dominguez Crespo Hirata R. Mycophenolic acid pharmacogenomics in kidney transplantation. J Transl Genet Genom. 2020;4:320–55.